Home All News Stand Down.

Stand Down.

We get paid to be suspicious when we’ve got nothing to be suspicious about.

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.

1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...

Billions Lost in These Two Healthcare Spacs.

What Could Possibly go Wrong Investing in a Couple Billion Dollar Healthcare Giants? Apparently Everything!

Video: The Coming Collapse Of Crypto! (Tether Again)

https://youtu.be/Odoqs0lBHLY RELATED: Bitcoin $30,000. Time to Bargain Hunt? Read This First.

Short Selling Contest | Enter by September 30th.

Sep 18, 2023 Send entries to [email protected] by midnight Sept. 30. If you prefer old-fashioned mail, write to John...

Video: How Unfunded Pensions Will Destroy Your Retirement.

VIDEO https://youtu.be/pkB5ugK0YDY Speaks slow enough to set speed at 1.25 to 1.5

Stand Down. “A Super Bubble” says Jeremy Grantham, the “Day of Reckoning is Here”...

Calling a Super Bubble. | Front Row with Jeremy Grantham https://youtu.be/JlEGU2ypr1Q

Remember this?

What once looked liked a barrel of fun, now looks like shark infested waters. @chuttersnap

1.9 Trillion Trades on OTCMarkets in May. Thumbs up or Buyer Beware?

An increase of more than 2,000 percent from a year earlier! Penny...
Internet Stock Review

Stand Down: Does Uber’s Valuation Make Sense?

Uber's IPO Valuation Makes No Sense (Forbes). The most anticipated IPO in years is almost here....

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...